Literature DB >> 8737416

Steroid metabolizing enzymes in pluripotential progenitor central nervous system cells: effect of differentiation and maturation.

R C Melcangi1, P Froelichsthal, L Martini, A L Vescovi.   

Abstract

A novel in vitro system which allows extensive culturing of multipotential stem cells from mouse brain has made it possible to test whether enzymes that metabolize androgens and progestagens are present in undifferentiated central nervous system progenitor cells. Embryonic day 14 striatal cells were grown in the presence of either 20 ng/ml of epidermal growth factor (which prevents cell differentiation), or 2% fetal bovine serum (facilitating differentiation). Differentiation was complete by 35 days in vitro when the cell population comprised 86 +/- 2.0% astrocytes, 6 +/- 0.7% neurons 1.6 +/- 0.5% oligodendrocytes and 6.4 +/- 0.5% undifferentiated cells. No changes in the proportions of cell type were observed thereafter (38 and 45 days in vitro). 5 alpha-Reductive conversion (by 5 alpha-reductase) of testosterone and progesterone into dihydrotestosterone and dihydroprogesterone, and subsequent 3-alpha hydroxylation (by 3 alpha-hydroxysteroid dehydrogenase) to 3 alpha-diol and tetrahydroprogesterone were assayed in the cultures at 35, 38 and 45 days in vitro. Undifferentiated epidermal growth factor-treated cells (controls) formed about 10 times more dihydroprogesterone than dihydrotestosterone. Conversions of dihydrotestosterone and dihydroprogesterone, respectively, into 3 alpha-diol and tetrahydroprogesterone were very similar. In the fetal bovine serum-treated differentiating cells, 5 alpha-reductase converting progesterone increased at 38 days in vitro, and remained similarly elevated at 42 days in vitro (4 times). However, the conversion of testosterone into dihydrotestosterone remained at control levels up to 42 days in vitro when an increase was observed. 3 alpha-Hydroxysteroid dehydrogenase activity converting dihydroprogesterone but not dihydrotestosterone was increased at 38 and 42 days in vitro. These results show that undifferentiated central nervous system cells possess androgen and progestagen metabolizing enzymes which are strongly influenced by the cellular differentiation/maturation process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737416     DOI: 10.1016/0306-4522(95)00522-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression.

Authors:  Jun Ming Wang; Patrick B Johnston; Bret Gene Ball; Roberta Diaz Brinton
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

2.  Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2.

Authors:  Lifei Liu; Junming Wang; Liqin Zhao; Jon Nilsen; Kelsey McClure; Karren Wong; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

3.  Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism.

Authors:  R C Melcangi; I Cavarretta; V Magnaghi; M Ballabio; L Martini; M Motta
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

4.  Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.

Authors:  Ronald W Irwin; Jun Ming Wang; Shuhua Chen; Roberta Diaz Brinton
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-12       Impact factor: 5.555

Review 5.  Synthetic neurosteroids on brain protection.

Authors:  Mariana Rey; Héctor Coirini
Journal:  Neural Regen Res       Date:  2015-01       Impact factor: 5.135

Review 6.  Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.

Authors:  Ronald W Irwin; Christine M Solinsky; Roberta Diaz Brinton
Journal:  Front Cell Neurosci       Date:  2014-07-30       Impact factor: 5.505

Review 7.  Androgen Effects on Neural Plasticity.

Authors:  Nariko Kuwahara; Kate Nicholson; Lauren Isaacs; Neil J MacLusky
Journal:  Androg Clin Res Ther       Date:  2021-12-23

Review 8.  Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.

Authors:  Jun Ming Wang; Ronald W Irwin; Lifei Liu; Shuhua Chen; Roberta Diaz Brinton
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

Review 9.  Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease.

Authors:  Ari Loren Mendell; Neil James MacLusky
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.